Per the multiple posts here and on various blogs regarding BTD, Brigatinib could be authorized for sale by FDA well before 2-3 years, and given previous examples it could be as early as tomorrow. July is the projected approval date if you use mean BTD/Market approval timing for previously approved BTD molecules. No news here.